Re: KI Inquiry -Reply

["Spell, Bill" <bills@deq.state.la.us>]

Franz, I don't know what the dose would be from eating one or two shrimp, 
but I suspect it is very small.  However, it is enough to produce an adverse 
reaction in SOME people......and to varying degrees, depending on the 
person.

The problems in parts of Europe are not the same as in some parts of this 
country.  Evacuation is frequently done in low-lying areas, such as when a 
hurricane approaches, and the same types of plans are used in planning for a 
nuclear emergency.  In fact, in our state, the petrochemical industries have 
"borrowed" evacuation plans and methods from the nuclear utilities, since 
the same local agencies respond to both.  It works, too.

These are my personal opinions, based on some observation, of course.

Bill
bills@deq.state.la.us
 ----------
From: radsafe
To: Multiple recipients of list
Subject: Re: KI Inquiry -Reply
Date: Thursday, October 17, 1996 6:31PM

At 17:39 17.10.1996 -0500, you wrote:
>It has been my understanding that KI is used solely for Emergency
>Workers.  The public should be evacuated long in advance to prevent
>them from receiving a dose to the thyroid.  I know there are some states
>that administrar KI to the general public, but I'm not familiar with those
>State's plans and procedures.
>
>I apologize for missing the beginning messages regarding KI, but I had to
>throw in my two cents!
>
>These are my opinions, and not those of the US EPA or other government
>agencies.
>
>=======================================================================0

Your understanding is wrong. KI is routineously distributed to households in
the vicinity of nuclear power plants - at least in Europe. In the case of a
very severe accident it should be adminstered to the population of large
areas. Where to evacuate the public of a town of several million inhabitants
to????? KI-tablets were distributed recently to the public in Austria - or
rather to everybody, who wanted to collect them. I think that the public was
only little interested in it. The possible adverse effect is something which
influence the decision on reduction of the KI dose.

Franz
Schoenhofer
Habichergasse 31/7
A-1160 WIEN
AUSTRIA/EUROPE
Tel./Fax:       +43-1-4955308
Tel.:           +43-664-3380333
e-mail:         schoenho@via.at